High throughput assay for the simultaneous or separate detection of human immunodeficiency virus (HIV) and hepatitis type C virus (HCV)

Infusionstherapie und Transfusionsmedizin

Volumn 25, Issue 2-3, 1998, Pages 164-169

  McDonough, S H ^a   Giachetti, C ^a   Yang, Y ^a   Kolk, D P ^a   Billyard, E ^a   Mimms, L ^a  

^a Gen Probe Incorporated   (United States)

Author keywords

Blood screening; HCV; High throughput; HIV; Nucleic acid amplification

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DNA DETERMINATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEIC ACID ANALYSIS; SCREENING TEST; VIRUS DETECTION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; TYPE C VIRUS;

EID: 0031837652     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053415     Document Type: Article

References (13)

1. Busch MP, Stramer SL, Kleinman SH: Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives; in Garrity G (ed): Applications of Molecular Biology to Blood Transfusion Medicine. Bethesda, MD, American Association of Blood Banks, 1997, pp 123-176.
2. Busch MP, Lee LLL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR: Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1994;35:91-97.
3. Schreiber GB, Busch MP, Kleinman SH, Korelitz, JJ, for the Retrovirus Epidemiology Study: The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
4. Stramer SL, Aberle-Grasse J, Brodksy JP, Busch MP, Lackritz EM: US blood donor screening with p24 antigen (Ag): One year experience. Transfusion 1997:37(suppl: S1).
5. Committee for Proprietary Medicinal Products: Plasma-derived medicinal products. The introduction of genomic amplification technology (GAT) for the detection of Hepatitis C virus RNA in plasma pools. CPMP/BWP/390/97, October 22, 1997.
6. Kacian DL, Fultz TJ: Nucleic acid sequence amplification methods. U.S. Patent 5,399,491, 1995.
7. Arnold LJ, Hammond PW, Wiese WA, Nelson NC: Assay formats involving acridinium-ester-labeled DNA probes. Clin Chem 1989;35:1588-1594.
8. Nelson NC, BenCheikh A, Matsuda E, Becker M: Simultaneous detection of multiple nucleic acid targets in a homogeneous format. Biochemistry 1996;35:8429-8438.
9. Lin HJ, Myers LE, Yen-Lieberman B, Hollinger FB, Henrard D, Hooper CJ, Kokka R, Kwok S, Rasheed S, Vahey M, Winters MA, McQuay LJ, Nara PL, Reichelderfer P, Coombs RW, Jackson JB: Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-562.
10. Arnold C, Barlow KL, Kaye S, Loveday C, Balfe P, Clewley JP: HIV type 1 sequence subtype G transmission from mother to infant: Failure of variant sequence species to amplify in the Roche Amplicor test: AIDS Res Hum Retroviruses 1995;11:999-1001.
11. Barlow KL, Tosswill JHC, Parry JV, Clewley JP: Performance of the Amplicor Human Immunodeficiency Virus type 1 PCR and analysis of specimens with false-negative results. J Clin Microbiol 1997;35:2846-2853.
12. Centers for Disease Control and Prevention: Identification of HIV-1 Group O infection - Los Angeles County, California, 1996. MMWR 1996;45:561-565.
13. Vandamme A-M, Schmit J-C, Van Dooren S, Van Laethem K, Gobbers E, Kok W, Goubau P, Witrouw M, Peetermans W, De Clercq E, Desmyter J: Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the Amplicor HIV Monitor test. J AIDS Hum Retroviruses 1996;13:127-139.